These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9756792)

  • 21. Central nervous system toxicity of quinolones: human and animal findings.
    Christ W
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():219-25. PubMed ID: 2124211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of quinolones on granulocyte function in vitro.
    Boogaerts MA; Malbrain S; Scheers W; Verwilghen RL
    Infection; 1986; 14 Suppl 4():S258-62. PubMed ID: 3469158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative brain microdialysis study on the mechanism of quinolones distribution in the central nervous system.
    Ooie T; Terasaki T; Suzuki H; Sugiyama Y
    Drug Metab Dispos; 1997 Jul; 25(7):784-9. PubMed ID: 9224772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    Fukuda H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs.
    Nagai A; Miyazaki M; Morita T; Furubo S; Kizawa K; Fukumoto H; Sanzen T; Hayakawa H; Kawamura Y
    J Toxicol Sci; 2002 Aug; 27(3):219-28. PubMed ID: 12238145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxicity and uptake of pefloxacin, ciprofloxacin, and ofloxacin in primary cultures of rat hepatocytes.
    Nordmann P; Pechinot A; Kazmierczak A
    J Antimicrob Chemother; 1989 Sep; 24(3):355-63. PubMed ID: 2808191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pefloxacin activity against recent clinical isolates.
    Lembo M; Covelli B; Nani E; Lavitola A
    J Chemother; 1991 Jan; 3 Suppl 1():51-3. PubMed ID: 12041785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of enoxacin, norfloxacin and pefloxacin on polymorphonuclear leukocytes chemiluminescence.
    Aquilini D; Bartoloni A; Paradisi F
    J Chemother; 1991 Jan; 3 Suppl 1():116-8. PubMed ID: 12041743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Kindling of rat epilepsy by intracerebroventricular injection of norfloxacin and ultrastructural changes of brain].
    Qian YS; Lu J; Huang ZS; Fan WZ; Xu C; Chen Y
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):373-5. PubMed ID: 9812728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norfloxacin-induced electroencephalogram alteration and seizures in rats are not triggered by enhanced levels of intracerebral glutamate.
    Chenel M; Limosin A; Marchand S; Paquereau J; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3660-2. PubMed ID: 14576142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of fluoroquinolones on cultured articular chondrocytes flow cytometric analysis of free radical production.
    Thuong-Guyot M; Domarle O; Pocidalo JJ; Hayem G
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1544-9. PubMed ID: 7996468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in brain interleukin-1beta following the coadministration of norfloxacin with biphenylacetic acid in rats.
    Zhang LR; Li XT; Tang WL; Wang YM; Cheng NN; Chen BY
    Eur J Pharmacol; 2006 Aug; 543(1-3):21-6. PubMed ID: 16824509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents.
    Hayem G; Petit PX; Levacher M; Gaudin C; Kahn MF; Pocidalo JJ
    Antimicrob Agents Chemother; 1994 Feb; 38(2):243-7. PubMed ID: 8192451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetration of pefloxacin and its desmethyl metabolite into the uroepithelium after a 800-mg single oral dose in human patients.
    Moreau JL; Royer-Morrot MJ; Lozniewski A; Trackoen G; Delavault P; Royer RJ
    Eur J Clin Pharmacol; 1996; 49(5):401-5. PubMed ID: 8866637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse testicular effects of some quinolone members in rats.
    Abd-Allah AR; Aly HA; Moustafa AM; Abdel-Aziz AA; Hamada FM
    Pharmacol Res; 2000 Feb; 41(2):211-9. PubMed ID: 10623489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats.
    Cadart M; Marchand S; Pariat C; Bouquet S; Couet W
    Pharm Res; 2002 Feb; 19(2):209-14. PubMed ID: 11883649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of permeability into rat cerebrospinal fluid of the quinolones: dependency on their lipophilicities.
    Ichikawa N; Naora K; Iwamoto K
    Biol Pharm Bull; 1994 Jan; 17(1):152-5. PubMed ID: 8148807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative in-vitro activity of pefloxacin.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinolones.
    Shah PM
    Prog Drug Res; 1987; 31():243-56. PubMed ID: 3326031
    [No Abstract]   [Full Text] [Related]  

  • 40. Determination of pefloxacin and its main active metabolite in human serum by high-performance liquid chromatography.
    Abanmi N; Zaghloul I; El Sayed N; Al-Khamis KI
    Ther Drug Monit; 1996 Apr; 18(2):158-63. PubMed ID: 8721279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.